Year None202620252024202320222021202020192016201520142006 Jun 09, 2026 CVRx Announces Chief Financial Officer Transition May 27, 2026 CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference May 20, 2026 CVRx to Present at the William Blair 46th Annual Growth Stock Conference May 14, 2026 CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy May 11, 2026 CVRx Reports First Quarter 2026 Financial and Operating Results May 04, 2026 CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population Apr 27, 2026 CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 Apr 20, 2026 CVRx Announces Nomination of Michael Dale for Election to the Board of Directors Apr 13, 2026 CVRx Reports Preliminary First Quarter 2026 Financial Results Mar 02, 2026 CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting Pagination Current page 1 Page 2 Next page next Last page last Displaying 1 - 10 of 15
